In this three-part podcast series, "Trial Trailblazers: Behind clinical breakthroughs," gain rare insight into the human stories driving innovative clinical research. From pioneering treatments for rare pediatric diseases to exploring natural killer cells for Alzheimer's and developing FDA-approved digital therapeutics for fibromyalgia, each episode reveals the scientific ingenuity and personal determination behind medical advances. Industry leaders share practical wisdom on navigating regulatory pathways, securing funding, and bringing novel treatments to patients who need them most.
Check out the podcast episodes!
⬆- Ep. 3 Digital Behavioral Therapy for Fibromyalgia
- Ep. 2 Natural Killer Cells Show Promise in Alzheimer’s Trials
- Ep. 1 Pioneering Treatments for Rare Pediatric Diseases
Ep. 3
Digital Behavioral Therapy for Fibromyalgia
In Episode 3 of the Trial Trailblazers podcast, discover how a company transformed behavioral therapy into an FDA-approved digital treatment for fibromyalgia. Explore the journey from concept to commercialization, including decentralized trial design, patient recruitment strategies, and regulatory navigation.
Ep. 2
Natural Killer Cells Show Promise in Alzheimer’s Trials
In Episode 2 of "Trial Trailblazers," experts discuss how natural killer cells, used in cancer treatment, show promise for Alzheimer's. Learn about a compassionate use case that led to FDA fast-track designation and hear inspiring patient stories of this groundbreaking approach.
Ep. 1
Pioneering Treatments for Rare Pediatric Diseases
In Episode 1 of "Trial Trailblazers," explore the challenges of developing treatments for rare pediatric diseases. Hear about innovative study designs and strategies for engaging caregivers and recruiting patients when standard protocols don't apply.
